Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease.
Tabaton
Massimo
M
Department of Neuroscience, University of Genova, Genova, Italy.
Perry
George
G
Zhu
Xiongwei
X
Lee
Hyoung-gon
HG
Casadesus
Gemma
G
Smith
Mark A
MA
D000544:Alzheimer Disease / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D000682:Amyloid / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003210:Concept Formation / Q000502:physiology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008559:Memantine / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D008822:Mice, Transgenic; D013045:Species Specificity
D000682:Amyloid; D000978:Antiparkinson Agents; D008559:Memantine